Darbà, JosepMarsà, Alícia2021-06-102022-05-042021-05-041473-7167https://hdl.handle.net/2445/178242Intrahepatic cholangiocarcinomas (iCCA) are aggressive tumors, often diagnosed in advanced stages and with limited curative treatment options. Their incidence has raised in the past years, increasing their associated economic burden. This study aimed to measure hospital incidence and mortality of iCCA and to evaluate direct medical costs.-3822 p.application/pdfeng(c) Informa Healthcare, 2021Cost de l'assistència sanitàriaGestió hospitalàriaHepatitisMalalties del fetgeCost of medical careHospital administrationHepatitisLiver diseasesinfo:eu-repo/semantics/article7039782021-06-10info:eu-repo/semantics/openAccess